Муцинозные опухоли яичников различного потенциала злокачественности
Диссертация
По данным мировой литературы 5-летняя выживаемость больных не превышает 30%. Остаются неудовлетворительными и результаты лечения распространенных стадий рака яичников: 3-х и 5-летняя выживаемость больных составляет 20% и 1,3%, а при муцинозном раке яичников — 21% и 9%, соответственно. Такие низкие показатели выживаемости объясняются поздней диагностикой, связанной с бессимптомным течением… Читать ещё >
Список литературы
- Буланов М.Н. Значение трансвагинальной цветовой допплерографии в сочетании с импульсной допплерометрией для дифференциальной диагностики добркачественных и злокачественных новообразований яичников. Дис.: канд. мед. наук. М., 1998.
- Глазунов М.Ф. Опухоли яичников. Л., 1961, с. 336.
- Губина О.В. Особенности клинического течения и лечения пограничных опухолей яичников. Дис.: канд. мед. наук. М., 1995.
- Жорданиа К.И. Злокачественные эпителиальные опухоли яичников. Современная онкология. 2000: Том 2 № 2 стр. 51−55.
- Зборовская И.Б., Ельчева И. А. Молекулярно-генетические исследования при раке яичников (сборник «Современные экспериментальные и клинические подходы к диагностике и рациональному лечению рака яичников под. ред. проф. В.А. Горбуновой).М., 2001, с. 10−31.
- Свердлова Е.С. Муцинозные опухоли яичников. Дисс. канд. мед. наук, Томск, 1995.
- Татосян А.Г. Онкогены. В кн. Канцерогенез под ред. Заридзе Д. Г., М., 2000, с. 57−74.
- Трапезников H.H., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ (состояние онкологической помощи, заболеваемость и смертность). М., 2001, с. 95−96.
- Чекалова М. А. Ультразвуковая диагностика рака яичников. Сборник «Современные экспериментальные и клинические подходы к диагностике и рациональному лечени рака яичников» по ред. Горбуновой В. А. Москва, 2001, стр. 47−65.
- Aiman JA, Forney JP., Parker CR. Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women. Obstet. Gynecol. 1986- 68:1.
- Alvarez RD., Varner RE. Hyperandrogenic state associated with a mucinous cystadenoma. Obstet. Gynecol.1987- 69(3):507−10.
- Aunoble B., Sanches R., Didier E., Bignon Y. Maior oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int. J. Oncology, 2000, 16(3), 567−576.
- Baergen RN, Rutgers JL. Classification of mural nodules in common epithelial tumors of the ovary. Adv Anat Pathol 1995:2:346−51.
- Baergen RN, Rutgers JL. Mural nodules in common epithelial tumors of the ovary. Int J Gynecol Pathol 1994:13:62−72.
- Baradi H., Ponsky J. Pseudomyxoma peritonei. Surgery 2002- 131:
- Barakat RR, Rubin SC, Wong G, et al 1992 Mixed mesodermal tumor of the ovary: analisis of prognostic factors in 31 cases. Obstetries and Gynecology 80: 660−664.
- Barlogie B., Cony P. M., Drewinko B.// Cancer Res. 1987.- Vol.40. — P. 1165−1168.
- Barnhill D., Heller P., Brzozowski P., Advani H., Gallup D., Park R. Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 1985−65:53−9.
- Beck RP, Latour JP. A review of 1019 benign ovarian neoplasms. Obstet Gynecol 1960:16:479−82.
- Berchuck A. Biomarkers in the ovari. J. Cell Biochem Suppl 1995, 23, 223 226.
- Berchuck A., Kamel A., Whitaker R., Rodrigues G. et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. // Cancer Res 1990, 50: 4087 -4091.
- Bewtra C, Watson P, Conway T, et al. Hereditary ovarian cancer: a clinicopathological study. Int J Gynecol Pathol 1992−11:180−7.
- Bostwick D.G., Tazelaar H.D., Ballon S.C., Hendrickson M.R., Kempson R.L. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986−58:2052−65.
- Bouzourene H., Genton C. Y. Les tumeurs mucineuses de l, ovaire. Aspects anatomo-cliniques, classification histologique, facteurs pronostiques et histogenese. Arch Anat Cytol Path, 1997, 45, n 4, 192−198.
- Burger HG, Bailie A., Drummond A.E., Healy DL, Jobling Т., Mamers P, et al. Ингибин и рак яичников. Вопросы онкологии. 1999, том 45, № 4 стр. 369−373.
- Cadron I., leunen К., Van Gorp Т., Amant F., Neven P., Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol. 2007 Jul 10- 25(20):2928−37.
- Cancer: Principles and Practice of Oncology, Fourth Edition, edited by Vincent T. DeVita, Jr., Samuel Hellman, Steven A. Rosenberg. J.B. Lippincott Co., Philadelphia, 1993.
- Chan J. K, Tian C., Monk B.J., Herzog T. Et al. Prognostic factors for high-risk early-stage epithelian ovarian cancer: a Gynecologic Oncology Group study. Cancer 2008 May 15−112(10):2202−10.
- Cariker M., Dockery M. Mucinous cystadenomas and mucinous cystadenocarcinomas of the ovary. Cancer 1954−7:302−10.
- Casey A., Bell D., Lage J., Fuller A., Nikrui N., Rice L. Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol 1993−50:316−22.
- Chaitin B.A., Gershenson D.M., Evans H.L. Mucinous tumors of the ovary: a clinicopathologic study of 70 cases. Cancer 1985−55:1958−62.
- Chambers JT, Merino MJ, Kohorn EI, Schwartz PE. Borderline ovarian tumors. Am J Obstet Gynecol 1988−159:1088−94.
- Chan YF, Ho HC, Yau SM, Ma L. Ovarian mucinous tumor with mural nodules of anaplastic carcinoma. Gynecol Oncol 1989:35:112−9.
- Chandran R., Rahman H, Gebbie D 1993 Composite mucinous and granulose-theca-cell tumour of the ovary: an unusual neoplasm. Australian and New Zealand Journal of Obstetrics and Gynaecology 33:437−439.
- Chen S., Wang W.C., Zhou C., Zhou N.N., Yang Z.H., Zhao W.F., Li S.Y., Li G.Z. Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging. Chin Med Sci J. 2006 Dec-21(4):270−5.
- Chiaffarino F., Parazzini F., Bosetti C., Franceschi S., Talamini R., Canzonieri V., Montella M., Ramazzotti V., Franceschi S., La Vecchia C. Risk factors for ovarian cancer histotypes. Eur J Cancer. 2007 May-43(7): 1208−13.
- Cho S.M., Byun J.Y., Yang D.H., Lee J.M., Shinn S.H. Ovarian mucinous1. Thand serous cystadenocarcinoma: CT and MR differentition. Abstr. 97 Annu. Meet. Amer. Roentgen Ray Soc., Boston, May 4−9, 1997.
- Chuaqui RF, Zhuang Z, Emmert-Buck MR, et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 1996−27:165−71.
- Clarke TJ. Sarcoma-like mural nodules in cystic serous ovarian tumours. J Clin Pathol 1987:40:1443−8.
- Collins R.J., Cheung A., Ngan H.Y., et al. 1991 Primary mixed neuroendocrine and mucinous carcinoma of the ovary. Archives of Gynecology and Obstetrics 248: 139−143.
- Czernobilsky B., Dgani R., Roth L. Ovarian muconous cystadenocarcinoma with mural nodule of carcinomatous derivation. Cancer 1983−51:141−148.
- Dabbs DJ, Sturtz K, Zaino RJ. The immunohistochem-ical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996:27:172−7.
- De Rosa G, Donofrio V, De Rosa N, Fulciniti F, Zeppa P. Ovarian serous tumor with mural nodules of carcino-matous derivation (sarcomatoid carcinoma): report of a case. Int J Gynecol Pathol 1991:10:311−8.
- Domanska K., Malander S. et al. Ovarian cancer at yong age: the contribution of mismatch-repair defects in a population-basedseries of epithelial ovarian cancer before age 40. Int J Gynecol Cancer. 2007 Jul-Aug- 17(4):789−93.
- Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG, McGuckin MA. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumors. J Pathol- 183(3):311−7 1997.
- Esquivel J, Sugarbaker PH. Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg 2000 Oct-87(10): 1414−8.
- Fernandez-del Castillo C. Mucinous cystic neoplasms. J Gastrointest Surg. 2008 Mar- 12(3): 411−3.
- Finberg H. Variable echogenicity in ovarian mucinous tumors. J Ultrasound Med. 2007 Apr-26(4):554.
- Fujii S, Konishi I, Kobayashi F, Okamura H, Yamabe H, Mori T. Sarcomalike mural nodules combined with a microfocus of anaplastic carcinoma in mucinous ovarian tumor. Gynecol Oncol 1985:20:219−33.
- Gadducci A, Ferdeghini M, Prontera C, et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol 1992:44:147−54.
- Gough DB, Donohue JH, Schutt AJ, Gonchoroff n, Goellner JR, Wilson T.O., Naessens JM, 0, Brien PC, van Heerden JA. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994 Feb-219(2): 112−9.
- Greggi S, Genuardi M, Benedetti-Panici P, et al. Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases. Gynecol Oncol 1990−39:300−4.
- Guerrieiri C, Franlund B, Fristedt S, Gillooley JF, Boeryd B. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression. Hum Pathol 1997 Sep- 28(9): 1039−45.
- Guerrieri C, Hogberg T, Wingren S, Fristedt S, Simonsen E, Boeryd B. Mucinous borderline and malignant tumors of the ovary: a clinicopathologic and DNA ploidy study of 92 cases. Cancer 1994:74:2329−40.
- Haran D., Yarden J. Molecular mechanism underlying / HER-2 action in breast cancer. Oncogene, 2000, 19, 53, 6102−6109.
- Harrison M.L., Jameson C., Gore M.E. Mucinous ovarian cancer. Int J Gynecol Cancer. 2008 Mar-Apr- 18(2):209−14.
- Hart WR. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol 1977- 8:541−9.
- Harvey A. Risch, Loraine D. Marrett, Meera Jain, Geoffrey R. Howe. Am J. Epidemiol 1996- 144: 363−72.
- Hasholzner U, Baumgarthner L., Stieber P., Meier W, Hofmann K., Fateh-Moghadam A. Significance of the tumor markers CA 125|| and CA 72−4, CASA and CYFRA 21−1 in ovarian carcinoma. Anticancer Res 1994 Nov-Dec- 14(6B):2743−6.
- Hasholzner U, Baumgarthner L., Stieber P., Meier W, Reiter W., Pahl H., Fateh-Moghadam A. Clinical significance of the tumor markers CA 125 and CA 72−4 in ovarian carcinoma. Cancer- 69(4): 329−34 1996.
- Hauptmann S. Differential diagnosis of ovarian metastases. Pathologe 2007 May-28(3):215−21
- Healy DL, Burger HG, Mamers P, et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Bngi J Mod 1993−329:1539−42.
- Hoerl HD, Hart WR. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up. Am J Surg Pathol 1998−22:1449−62.
- Hynes N.E. ErbB2 activation and signal transduction in normal and malignant mammary cells. J Mammary Gland Biol Neoplasia, 1996, 1(2): 199−206.
- Jordan S.J., Green A.C., Whiteman D.C., Webb P.M. Risk factors for benign serous and mucinous epithelial ovarian tumors. Obstet Gynecol 2007 Mar-109(3):647−54.
- Jylling AM., Jorgensen L., Holund B. Mucinous cystadenocarcinoma in combination with hemangiosarcoma in the ovary. Pathol Oncol Res- 5(4):318−9 1999 Ul.
- Kaern J, Trope CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review ofclinicopathologic features and treatment modalities. Cancer 1993−71:1810−20.
- Kaern J, Trope CG, Kristensen G., Abeler VM., Petterse E. DNA ploidy: the most impotant prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 1993−3:349−58.
- Kahn MA, Demopoulos RL Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopathological study Int J Gynecol Pathol 1992- 11:15−23.
- Karen Kinkel, MD, Hedvig Hricak, MD, PhD, Ying Lu, PhD, Kyo Tsuda, MD and Roy A. Filly, MD. US Characterization of Ovarian Masses: A Meta-Analysis. Radiology. 2000−217:803−811.
- Khunamornpong S, Russel P, Dalrymple JC. Proliferating (LMP) mucinous tumors of the ovaries with microinvasion: morphological assessment of 13 cases. Int J Gynecol Pathol 1999−18:238−46.
- Kikkawa F., Nava A., Kajiyama H., Shibata K., Ino K., Nomura S. Clinical characteristics and prognosis of mucinous tumors of the ovary. Gynecol Oncol. 2006 Oct-103(l):171−5.
- Ko M.L., Pan H.S. Identical twins with ovarian endometriosis and mucinous borderline tumor: an unusual association. Fertil Steril. 2008 Oct- 90(4): 1200.
- Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 1989,74:9216.
- Kumar R., Mandal M., Vadlamudi R. New insights into anti-HER-2 receptor monoclonal antibody research. Semin Oncol, 2000, 6, 84−91.
- Kuoppala T, Heinola M., Aine R., Isola J., Heinonen PK. Serous and mucinous borderline tumors of the ovary: a clinicopathologic and DNA ploidy study of 102 cases. Int J Gynecol Cancer 1996−6:302−8.
- Kurman R.J., Visvanathan K., Roden R., Wu T.C., Shin IeM. Early detection and treatment of ovarian cancer- shifting from early stade to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol. 2008 Apr- 198 (4):349−50.
- Langley FA, Cummins PA, Fox H. An ultrastructural study ofmucin secreting epithelia in ovarian neoplasms. Acta Path Microbiol Scand A. 1972−233:76−86.
- Lersch C, Frimberger E, Ott R, Classen M. Gray-scale sonographic findings in a patient with pseudomyxoma peritonei. J Clin Ultrasound 2001 mar-Apr-29(3): 186−91.
- Lifechitz-Mercer B, Dgani R, Jacob N, Fogel M, Czemo-bilsky B. Ovarian mucinous cystadenoma with leiomy-omatous mural nodule. Int J Gynecol Pathol 1990,9:80−5.
- Los G., Mutsaers P.H.A., Lenglet W.J.M. et al. Cancer Chemotherapy Pharmacology.-1990. P. 389−394.
- Los G., Sminia P., Havaeman J. et al. Proc. Am.Assoc. Cancer Res. 1989.603 p.
- Lucas G., Brindle SD., Greengard P. Pharmacol.Exp.Ther.-1971.- Vol. 178.-P. 562−566.
- Mackillop W.J., Pringle J.F. 1985 Stage 3 endometrial carcinoma: a review of 90 cases. Cancer 56: 2519.
- Massad L., Hunter V., Szpak C, Clarke-Pearson D., Greasman W. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 1991−78:1027−32.
- Matias-Guiu X, Aranda I, Prat J. Immunohistochemical study of sarcoma-like mural nodules in a mucinous cystadenocarcinoma of the ovary. Virchows Arch A. 1991−419:89−92.
- McDonald PC, Grodin JM, Edman CD, Vellios F., Siiteri PK. Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia. Obstet. Gynecol. 1976- 47(6):644−50.
- Michael H, Sutton G, Roth LM. Ovarian carcinoma with extracellular mucin production: reassessment of «pseudomyxoma ovarii et peritonei.» Int J Gynecol Pathol 1987−6:298−312.
- Modugno F, Weissfeld JL, Hill LM. Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound. Gynecol Oncol, 2000- 77:289−292.
- Mok C.H., Tsao S.W., Knapp R.C., Fishbaugh P.M., Lao C.C. Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res. — 1992.-52.-P. 5119.
- Morin-Papunen L.C., Butterworth S. A., Panton O. N., Klaassen D. J., Shah A. M., Mc Gregor G. I. Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei. Am J Surg 2002 May-183(5):529−32.
- Morita K., Ono Y., Fuui H et al. Incidence of p53 and K-ras alterations in ovarian mucinous and serous tumors. Pathol. Int., 2000, 50 (3), 219−223.
- Nakashima N., Nagasaka T., Otwa N., Nara Y., Fukata S., Fukatsu T., Takeuchi J. Ovarian epithelial tumors of borderline malignancy' in Japan. Gynecol Oncol 1990−38:90−8.
- Narod S, Tonin P, Lynch H, et al. History of BRCA1-associated ovarian tumors. (Letter). Lancet 1994- 343:236.
- Nayar R, Siriaunkgul S, Robbins KM, McGowan L, Ginzan S, Silverberg SG. Microinvasion in low malignant potential tumors of the ovary. Hum Pathol 1996−27:521−7.
- Nezhat F., Slomovitz B.M., Saiz AD., Cohen C.J. Ovarian mucinous cystadenocarcinoma with virilization: case report. Gynecologic Oncology 2002- 84:468−472.
- Nichols GE, Mills SB, Ulbright TM, Czemobilsky B, Roth LM. Spindle cell mural nodules in cystic ovarian mucinous tumors. A clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 1991- 15:105 562.
- Niwa K., Hirose R., Mizuno T., Hirose Y., Tamaya T. Pseudomyxoma peritonei and mucinous pyometral fluid arising from an ovarian borderline mucinous tumor: case report. Eur J Gynaecol Oncol 2007−28(2): 145−6.
- Nomura K, Aizawa S. Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analisis of 40 cases. Cancer 2000−89:1541−46.
- O’Hanlan KA. Resection of a 303.2-pound ovarian tumor. Gynecol Oncol 1994,54:365−71.
- Oliva E., Andrada E., Pezzica E., Prat J. 1993 Ovarian carcinomas with choriocarcinomatous differentiation. Cancer 72: 2441−2446.
- Olson SH., Mignone L., Nakraseive C., caputo TA., Baracat RR., Harlap S. Symptoms of ovarian cancer. Obstet. Gynecol.- 98(2):212−7 2001 UI: 11 506 835.
- Parmley T.N. Woodruff JD. The ovarian mesothelioma. Am J Obstet Gynecol 1974- 120:234−41.
- Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm, International Federation of Gynecologyand Obstetrics, 1991.
- Piver MS, Baker TR, Jishi MF, et al. Familial ovarian cancer: a report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981−1999. Cancer 1993−71:582−8.
- Powell DE., Low malignant potential tumors of the ovary: does microinvasion matter? Hum Pathol 1996−27:517−8.
- Prat J, Scully RE. Sarcomas in ovarian mucinous tumors: a report of two cases. Cancer 1979,44:1327−31.
- Prat J, Young RH, Scully RE. Ovarian mucinous tumors with foci of anaplastic carcinoma. Cancer 1982- 50:300−4.
- Price A., Russell P., Elliott P, Bannatyne P. 1990 Composite mucinous and granulose-theca-cell tumour of ovary: case report of a unique neoplasm. International Journal of Gynaecological Pathology 9: 372−378.
- Prayson RA, Hart WR, Petras RE 1994 Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. American Journal of Surgical Pathology 18:591−603.
- Purdie DM, Siskind V, Bain CJ, et al. Reproduction-related Risk Factors for Mucinous and Nonmucinous Epithelial Ovarian Cancer. Am J Epidemiol 2001−9:860−64.
- Rahilly MA, Candlish W, Al-Nafiissi A. Fibrosarcoma arising in an ovarian mucinous tumor.'a case report, hit J Gynecol Cancer 1994−4:211−4.
- Rice LW., Berkowitz RS., Mark SD., Yavner DL., Lage JM. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 1990−39:195−8.
- Riman T., Persson I., Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) — 49(6):695−707 1998 UI: 99 226 030.
- Ricci J.V. One hundred years of gynecology. Philadelphia: Blakiston, 1945.
- Risch HA, Marrett LD, Jain M, et al. Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case-control study. Am J Epidemiol 1996- 144:363−72.
- Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997−16:1−9.
- Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 1997−2:197−226.
- Rufford B.D., Jacobs I.J., Menon U. Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG 2007 Jan-l 14(l):59−64.
- Russell P, Famsworth A 1997 Surgical Pathology of the Ovaries, 2nd edn. New York: Churchill Livingston, 1989−217−35.
- Russell P. Borderline epithelial tumors of the ovary: a conceptual dilemma. Clin Obstet Gynecol 1984−11:259−77.
- Russell P. Common epithelial tumors of the ovary a new look. Pathol 1985−17:555−7.
- Russell P., Merkur H. Proliferating ovarian epithelial tumors: a clinicopathological analisys of 144 cases. Aust N Z J Obstet Gynecol 1979−19:45−51.
- Russell P. Surface epithelial-stromal tumors. In: Kurman R.J., Blausteins, s Pathology of the female genital tract. Chap 18, pp.724−737. New York, Spinger-Verlag, 1994.
- Russell P. The pathological assessment of ovarian neoplasms: I: introduction to the common epithelial tumours and analysis of benign epithelial tumours. Pathology 1979−11:5−26.
- Russell P. The pathological assessment of ovarian neoplasms: II: the proliferating epithelial tumours. Pathology 1979−11:251−82.
- Russell P. The pathological assessment of ovarian neoplasms: III: the malignant epithelial tumours. Pathology 1979- 11:493−532.
- Rutgers J.L., Scullu R. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 1988- 61:340−348.
- Samimi G., Ozbun L., Johnson M.E., Mok S.C. Birrer M.J. Biomarkers of mucinous tumors of the ovary. Dis Markers 2007−23(5−6):3 89−96.
- Scully R.E., Sobin L.H. Histological typing of ovarian tumours.2nd ed. Worid Health Organization international histological classification of tumours. Berlin: Springer-Verlag, 1999.
- Scully R.E. Ovary. In: Henson DE, Albores-Saavedra J, eds. The pathology of incipient neoplasia. Philadelphia: WB Saunders, 1993:283−300
- Scully R.E., Young R.H., Clement P.B. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. IN: Atlas of tumor pathology. 3rd series. Fascicle 23 (3F23). Washington, DS: Armed Forces Institute of Pathology, 1998.
- Seale WB. Sonographic findings in a patient with pseudomyxoma peritonei. Clin Ultrasound 1982−10:441−3.
- Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol 1993−17:22−34.
- Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Authors' reply to the editor. Am J Surg Pathol 1993−17:1070−1.
- Seung Eun Jung, MD, Jae Mun Lee, MD, Sung Eun Rha et al. CT and MR Imaging of Ovarian Tumors with Emphasis on Differential Diagnosis. Radiographics. 2002−22:1305−1325.
- Shimizu Y. Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma. Gan To Kagaku Ryoho- 24 Suppl 1 :61−9 1997.
- Shimizu Y., Nagata H., Kikuchi Y., Umezawa S., Hasumi K., Yokokura T. Cytotoxic agents active against mucinous adenocarcinoma of the ovary. Oncol Rep- 5(1):99−101 1998.
- Shin HJ, Sneige N Epithelial cells and other cytologic features of pseudomyxoma peritonei in patients with ovarian and/or appendiceal mucinous neoplasms: a study of 12 patients including 5 men. Cancer 2000 Feb 25−90(1): 17−23.
- Silva E.G., Kurman R.J., Russell P, Scully R.E. Symposium: ovarian tumors of borderline malignancy. Int J Gynecol Pathol 1996- 15:281−302.
- Siriaunkgul S., Robbins K. M., McGowan L., Silverberg S.G. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol 1995- 14:198 208.
- Sondergaard G, Kaspersen P. Ovarian and extraovar-ian mucinous tumors with solid mural nodules. Int J Gynecol Pathol 1991−10:145−55.
- Sumithran E, Susil BJ 1992 Concominant mucinous tumors of appendix and ovary. Result of a neoplasti c field Change? Cancer 70: 2980−2983.
- Sumithran E, Susil BJ, Looi LM. The prognostic significance of grading in borderline mucinous tumors of the ovary. Hum Pathol 1988−19:15−8.
- Sugarbaker PH., Kern K, Lack E. Malignant pseudomyxoma peritonei of colonic origin. Natural history and a presentation of a curative approach to treatment. Dis Colon Rectum 1987−30:772−9.
- Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995- 221:29−42.
- Sugarbaker PH., Stuart O.A., Vidal-Jove J. et al. Reg. Cancer Treat.-1993.-Vol.4.-P. 188−194.
- Suzuki M., Saito S., Saga Y., Ohwada M., Sato I. Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas. Cancer Genet Cytogenet 2000 Apr 15- 118(2): 132−5.
- Sykes PH., Quinn MA., Rome RM. Ovarian tumors of low malignant potential: a retrospective study of 234 patients. Int J Gynecol Cancer 1997−7:218−26.
- Tang L., Zheng M., Xiong Y., Ding H., Liu F. Y. Clinical characteristics and prognosis of epithelial ovarian cancer in young women. Ai Zheng. 2008 Sep-27(9):951−5.
- Taylor HC. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 1929−48:204−230.
- Ten M., Lee Y.S.- Lectin histochemistry of ovarian mucinous cystadenomas. Int J Gynecol Pathol 1991- 10: 170−176.
- Tepper R., Lerner-Geva L., Altaras M.M. et al. Transvaginal color flow imaging in the diagnosis of ovarian tumors. J. Ultrasound Med. 1995. V.14. № 10.P. 731−734.
- Tongsong T., Wanapirak C., Sukpan K., Khunamornpong S., Pathumbal A. Subjective sonographic assessment for differentiation between malignant and benign adnexal masses. Asian Pac J Cancer Prey 2007 Jan-Mar-8(l): 124−6.
- Totkas S, Schneider U, Schlag PM. Surgical and multimodal therapy of pseudomyxoma peritonei. Chirurg 2000 Aug-71(8):869−76.
- Tsujimura T, Kawano K. Rhabdomyosarcoma coexistent with ovarian mucinous cystadenocarcinoma: a case report. Int J Gynecol Pathol 1992−11:58−62.
- Ursin G, Peters RK, Henderson B.E. et al. Oral contraceptive use and adenocarcinoma of the cervix. Lancet 1994−344:1390−4.
- Vaira M, Scuderi S, Costamagna D, Barone R, Aghemo B, Mioli PR, De Simone M. Cytoreductive surgery and intraperitoneal hyperthermicantiblastic therapy (HAPP) in peritoneal carcinomatosis. Minerva Chir 2002 0ct-57(5):597−605.
- Viale G, Gambacorta M, Dell’Orto P, Coggi G. Co-expression of cytokeratins and vimentin in common epithelial tumors of the ovary: an immunocytochemical study of eighty-three cases. Virchows Arch A. 1988−413:91−101.
- Watkin W, Silva EG, Gershenson D.M. Mucinous carcinoma of the ovary: pathologic prognostic factors. Cancer 1992−69:208−12.
- Werth R Klinische und Anatomische Untersuchungen zur Lehre von den Bauchgeschwullsten und der Laparotomie. Arch Gynecol Obstet 1984−24:100−18.
- Wertheim I, Fleischhacker D, McLachlin CM, et al. 1994 Pseudomyxoma peritonei: a review of 23 cases. Obstetries and Gynecology 84: 17−21.
- Wirtzfeld DA, Rodriguez-Bigas M., Weber T., Petrelli NJ. Disseminated peritoneal adenomucinosis: a critical review. Ann surg Oncol 1999 Dec- 6(8): 797−801.
- Wittenberg J, Cook LS, Rossing MA, et al. Reproductive risk factors for mucinous and nonmucinous epithelial ovarian cancer. Epidemiology 1999−10:761−3.
- Wolpert H.R., Fuller A.F., Bell D.A. Primary mucinous carcinoid tumor of the ovary. A case report. Int J Gynecol Pathol 1989- 8:156−162.
- Wong H.F., Low J J., Chua Y., Busmanis I., Tay E.H., Ho T.H. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer 2007 Mar-Apr- 17(2):342−9.
- Yong-Yeon Jeong, MD, Eric K. Outwater, MD and Heoun Keun Kang, MD Imaging Evaluation of Ovarian Masses. Radiographics. 2000−20:1445−1470.
- Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991−15:415−29.
- Young RH, Gilks CB, Scully RE. Pseudomyxoma peritonei Letter. Am J Surg Pathol 1993−17:1068−70.
- Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary. Am J Surg Pathol 1989−13:748−56.
- Young RH, Scully RE. Mucinous ovarian tumors associated with mucinous adenocarcinoma of the cervix. A clinicopathological analysis of 16 cases. Int J Gynecol Pathol 1988−7:99−111.
- Young RH, Scully RE. Ovarian metastases from carcinoma of the gallbladder and extrahepatic ducts simulating primary tumors of the ovary: a report of 6 cases. Int J Gynecol Pathol 1990−9:60−72.
- Zanetta G., Lissoni A., Cha S. et al. Pre-operative morphological and color Doppler features of borderline ovarian tumors Br. J. Obstet. Gynaec. 1995 V. 102. P.990−996.